May 24, 2018
Prescript Pharmaceuticals Inc. is recalling 2 lots of clindamycin capsules because of incorrect storage instructions on the product label, according to the May 23, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects:
- 150-mg clindamycin capsules in 30-count M-Pak containers (NDC 00527-1382-01) from lot 0130126 (no expiration date available), and
- 300-mg clindamycin capsules in 28-count M-Pak containers (NDC 00527-1383-01) from lot 0130132 (Exp. 3/31/19).
The capsules were manufactured by Lannett Company Inc., packaged by Prescript Pharmaceuticals, and distributed in California.
Prescript Pharmaceuticals voluntarily issued the recall April 24, 2018. The FDA designated it a Class II recall May 14, 2018. Using tablets recalled under a Class II designation could cause temporary or medically reversible adverse health consequences or a remote probability of serious harm, according to the FDA.
Available with a prescription, clindamycin is an antibiotic medication used to treat a variety of bacterial infections.
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here